Skip to main content
SpringerLink
Log in

Percutaneous Microwave Ablation for Benign Focal Liver Lesions

  • Chapter
  • First Online:
Microwave Ablation Treatment of Solid Tumors

  • 1189 Accesses

Abstract

With the widespread use of imaging modalities and routine medical checkups, more liver lesions are found in the general population. The essential issue is to ensure the proper diagnoses of these lesions, and modern imaging technologies, such as ultrasound, computed tomography, and magnetic resonance imaging, play important roles in the differentiation between benign and malignant hepatic lesions. With the continuous improvement and development of imagings, most liver lesions can be diagnosed, so that clear management recommendations can be provided. For benign focal liver lesions, a regular follow-up strategy is commonly recommended. The indications for treatment of benign focal liver lesions must be very strict, such as with tumor-specific symptoms and complications. The management of these lesions has evolved following improvement in surgical techniques (including laparoscopy) and development in nonsurgical modalities, including transcatheter arterial embolization, radiofrequency ablation, and microwave ablation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

BFLL:

Benign focal liver lesion

FNH:

Focal nodular hyperplasia

HA:

Hepatic adenoma

HCH:

Hepatic cavernous hemangioma

MWA:

Microwave ablation

RFA:

Radiofrequency ablation

TAE:

Transcatheter arterial embolization

US:

Ultrasound

References

  1. Chiche L, Adam JP. Diagnosis and management of benign liver tumors. Semin Liver Dis. 2013;33(3):236–47.

    Article  PubMed  Google Scholar 

  2. Cong WM, Dong H, Tan L, Sun XX, Wu MC. Surgicopathological classification of hepatic space-occupying lesions: a single-center experience with literature review. World J Gastroenterol. 2011;17(19):2372–8.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Bartolotta TV, Midiri M, Galia M, Rollandi GA, Cademartiri F, Lagalla R, Cardinale AE. Characterization of benign hepatic tumors arising in fatty liver with SonoVue and pulse inversion US. Abdom Imaging. 2007;32(1):84–91.

    Article  CAS  PubMed  Google Scholar 

  4. Ehrl D, Rothaug K, Herzog P, Hofer B, Rau HG. “Incidentaloma” of the liver: management of a diagnostic and therapeutic dilemma. HPB Surg. 2012;2012:891787:1–14.

    Google Scholar 

  5. Oliva MR, Saini S. Liver cancer imaging: role of CT, MRI, US and PET. Cancer Imaging. 2004;4(Spec No A):S42–6.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Heiken JP. Distinguishing benign from malignant liver tumours. Cancer Imaging. 2007;7(Spec No A):S1–14.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Elsayes KM, Leyendecker JR, Menias CO, Oliveira EP, Narra VR, Chapman WC, Hassanien MH, Elsharkawy MS, Brown JJ. MRI characterization of 124 CT-indeterminate focal hepatic lesions: evaluation of clinical utility. HPB (Oxford). 2007;9(3):208–15.

    Article  Google Scholar 

  8. Trillaud H, Bruel JM, Valette PJ, Vilgrain V, Schmutz G, Oyen R, Jakubowski W, Danes J, Valek V, Greis C. Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol. 2009;15(30):3748–56.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Madrazo BL. Use of imaging studies to aid in the diagnosis of benign liver tumors. Gastroenterol Hepatol (N Y). 2011;7(10):683–5.

    Google Scholar 

  10. Albiin N. MRI of focal liver lesions. Curr Med Imaging Rev. 2012;8(2):107–16.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Chung YE, Kim MJ, Kim YE, Park MS, Choi JY, Kim KW. Characterization of incidental liver lesions: comparison of multidetector CT versus Gd-EOB-DTPA-enhanced MR imaging. PLoS One. 2013;8(6):e66141: 1–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Petri A, Höhn J, Kókai EL, Savanya GK, Lázár G. Surgery of benign liver tumors: indications for treatment: twenty years’ experience. Hepatogastroenterology. 2008;55(82–83):592–5.

    PubMed  Google Scholar 

  13. Hsee LC, McCall JL, Koea JB. Focal nodular hyperplasia: what are the indications for resection? HPB (Oxford). 2005;7(4):298–302.

    Article  Google Scholar 

  14. Clarke DL, Currie EJ, Madhavan KK, Parks RW, Garden OJ. Hepatic resection for benign non-cystic liver lesions. HPB (Oxford). 2004;6(2):115–9.

    Article  CAS  Google Scholar 

  15. Lin H, van den Esschert J, Liu C, van Gulik TM. Systematic review of hepatocellular adenoma in China and other regions.Systematic review of hepatocellular adenoma in China and other regions. J Gastroenterol Hepatol. 2011;26(1):28–35.

    Article  PubMed  Google Scholar 

  16. Kammula US, Buell JF, Labow DM, Rosen S, Millis JM, Posner MC. Surgical management of benign tumors of the liver. Int J Gastrointest Cancer. 2001;30(3):141–6.

    Article  CAS  PubMed  Google Scholar 

  17. Katkhouda N, Hurwitz M, Gugenheim J, Mavor E, Mason RJ, Waldrep DJ, Rivera RT, Chandra M, Campos GM, Offerman S, Trussler A, Fabiani P, Mouiel J. Laparoscopic management of benign solid and cystic lesions of the liver. Ann Surg. 1999;229(4):460–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Gigot JF, Hubert C, Banice R, Kendrick ML. Laparoscopic management of benign liver diseases: where are we? HPB (Oxford). 2004;6(4):197–212.

    Article  Google Scholar 

  19. Terkivatan T, de Wilt JH, de Man RA, van Rijn RR, Zondervan PE, Tilanus HW, IJzermans JN. Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg. 2001;136(9):1033–8.

    Article  CAS  PubMed  Google Scholar 

  20. Bonney GK, Gomez D, Al-Mukhtar A, Toogood GJ, Lodge JP, Prasad R. Indication for treatment and long-term outcome of focal nodular hyperplasia. HPB (Oxford). 2007;9(5):368–72.

    Article  Google Scholar 

  21. Buell JF, Tranchart H, Cannon R, Dagher I. Management of benign hepatic tumors. Surg Clin North Am. 2010;90(4):719–35.

    Article  PubMed  Google Scholar 

  22. Cristiano A, Dietrich A, Spina JC, Ardiles V, de Santibañes E. Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management. Updates Surg. 2014;66(1):9–21.

    Article  PubMed  Google Scholar 

  23. Mezhir JJ, Fourman LT, Do RK, Denton B, Allen PJ, D’Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR. Changes in the management of benign liver tumours: an analysis of 285 patients. HPB (Oxford). 2013;15(2):156–63.

    Article  Google Scholar 

  24. Sakata M, Syoji T, Nishiyama R, Taniguchi M, Yamazaki M, Higashi Y, Suzuki K, Kawamura T, Yonekawa H, Maruo H. Laparoscopic partial hepatectomy of focal nodular hyperplasia. Case Rep Gastroenterol. 2012;6(3):720–5.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Kamimura K, Nomoto M, Aoyagi Y. Hepatic angiomyolipoma: diagnostic findings and management. Int J Hepatol. 2012;2012:410781:1–6.

    Google Scholar 

  26. Nguyen KT, Gamblin TC, Geller DA. World review of laparoscopic liver resection-2,804 patients. Ann Surg. 2009;250(5):831–41.

    Article  PubMed  Google Scholar 

  27. Tanabe KK. The past 60 years in liver surgery. Cancer. 2008;113(7 Suppl):1888–96.

    Article  PubMed  Google Scholar 

  28. Feng ZQ, Huang ZQ, Xu LN, Liu R, Zhang AQ, Huang XQ, Zhang WZ, Dong JH. Liver resection for benign hepatic lesions: a retrospective analysis of 827 consecutive cases. World J Gastroenterol. 2008;14(47):7247–51.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Yamamoto T, Kawarada Y, Yano T, Noguchi T, Mizumoto R. Spontaneous rupture of hemangioma of the liver: treatment with transcatheter hepatic arterial embolization. Am J Gastroenterol. 1991;86(11):1645–9.

    CAS  PubMed  Google Scholar 

  30. Srivastava DN, Gandhi D, Seith A, Pande GK, Sahni P. Transcatheter arterial embolization in the treatment of symptomatic cavernous hemangiomas of the liver: a prospective study. Abdom Imaging. 2001;26(5):510–4.

    Article  CAS  PubMed  Google Scholar 

  31. Bozkaya H, Cinar C, Besir FH, Parildar M, Oran I. Minimally invasive treatment of giant haemangiomas of the liver: embolisation with bleomycin. Cardiovasc Intervent Radiol. 2014;37(1):101–7.

    Article  PubMed  Google Scholar 

  32. Hoekstra LT, Bieze M, Erdogan D, Roelofs JJ, Beuers UH, van Gulik TM. Management of giant liver hemangiomas: an update. Expert Rev Gastroenterol Hepatol. 2013;7(3):263–8.

    Article  CAS  PubMed  Google Scholar 

  33. Amesur N, Hammond JS, Zajko AB, Geller DA, Gamblin TC. Management of unresectable symptomatic focal nodular hyperplasia with arterial embolization. J Vasc Interv Radiol. 2009;20(4):543–7.

    Article  PubMed  Google Scholar 

  34. Birn J, Williams TR, Croteau D, Schwartz S, Sturza S, Getzen T. Transarterial embolization of symptomatic focal nodular hyperplasia. J Vasc Interv Radiol. 2013;24(11):1647–55.

    Article  PubMed  Google Scholar 

  35. Karkar AM, Tang LH, Kashikar ND, Gonen M, Solomon SB, Dematteo RP, D’Angelica MI, Correa-Gallego C, Jarnagin WR, Fong Y, Getrajdman GI, Allen P, Kingham TP. Management of hepatocellular adenoma: comparison of resection, embolization and observation. HPB (Oxford). 2013;15(3):235–43.

    Article  Google Scholar 

  36. Cui Y, Zhou LY, Dong MK, Wang P, Ji M, Li XO, Chen CW, Liu ZP, Xu YJ, Zhang HW. Ultrasonography guided percutaneous radiofrequency ablation for hepatic cavernous hemangioma. World J Gastroenterol. 2003;9(9):2132–4.

    PubMed  Google Scholar 

  37. Hinshaw JL, Laeseke PJ, Weber SM, Lee Jr FT. Multiple-electrode radiofrequency ablation of symptomatic hepatic cavernous hemangioma. AJR Am J Roentgenol. 2007;189(3):W146–9.

    Article  PubMed  Google Scholar 

  38. Park SY, Tak WY, Jung MK, Jeon SW, Cho CM, Kweon YO, Kim KC. Symptomatic-enlarging hepatic hemangiomas are effectively treated by percutaneous ultrasonography-guided radiofrequency ablation. J Hepatol. 2011;54(3):559–65.

    Article  PubMed  Google Scholar 

  39. van Vledder MG, van Aalten SM, Terkivatan T, de Man RA, Leertouwer T, Ijzermans JN. Safety and efficacy of radiofrequency ablation for hepatocellular adenoma. J Vasc Interv Radiol. 2011;22(6):787–93.

    Article  PubMed  Google Scholar 

  40. van Tilborg AA, Nielsen K, Scheffer HJ, van den Tol P, van Waesberghe JH, Sietses C, Meijerink MR. Bipolar radiofrequency ablation for symptomatic giant (>10 cm) hepatic cavernous haemangiomas: initial clinical experience. Clin Radiol. 2013;68(1):e9–14.

    Article  PubMed  Google Scholar 

  41. Gao J, Ke S, Ding XM, Zhou YM, Qian XJ, Sun WB. Radiofrequency ablation for large hepatic hemangiomas: initial experience and lessons. Surgery. 2013;153(1):78–85.

    Article  PubMed  Google Scholar 

  42. Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation of hepatocellular adenoma: initial experience in 10 patients. J Gastroenterol Hepatol. 2008;23(8 Pt 2):e422–7.

    Article  PubMed  Google Scholar 

  43. de Rave S, Hussain SM. A liver tumour as an incidental finding: differential diagnosis and treatment. Scand J Gastroenterol Suppl. 2002;236:81–6.

    Article  PubMed  Google Scholar 

  44. Ahmed M, Goldberg SN. Thermal ablation therapy for hepatocellular carcinoma. J Vasc Interv Radiol. 2002;13(9 Pt 2):S231–44.

    Article  PubMed  Google Scholar 

  45. Xu HX, Xie XY, Lu MD, Chen JW, Yin XY, Xu ZF, Liu GJ. Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation. Clin Radiol. 2004;59:53–61.

    Article  PubMed  Google Scholar 

  46. Erce C, Parks RW. Interstitial ablative techniques for hepatic tumours. Br J Surg. 2003;90:272–89.

    Article  CAS  PubMed  Google Scholar 

  47. Lu MD, Xu HX, Xie XY, Yin XY, Chen JW, Kuang M, Xu ZF, Liu GJ, Zheng YL. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol. 2005;40:1054–60.

    Article  PubMed  Google Scholar 

  48. Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee Jr FT. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology. 2005;236(1):132–9.

    Article  PubMed  Google Scholar 

  49. Liu FY, Yu XL, Liang P, Wang Y, Zhou P, Yu J. Comparison of percutaneous 915 MHz microwave ablation and 2450 MHz microwave ablation in large hepatocellular carcinoma. Int J Hyperthermia. 2010;26(5):448–55.

    Article  PubMed  Google Scholar 

  50. Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd 3rd GD, Dupuy DE, Gervais DA, Gillams AR, Kane RA, Lee Jr FT, Livraghi T, McGahan J, Phillips DA, Rhim H, Silverman SG, Solbiati L, Vogl TJ, Wood BJ, Vedantham S, Sacks D, Society of Interventional Radiology Technology Assessment Committee and the International Working Group on Image-guided Tumor Ablation. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2009;20(7 Suppl):S377–90.

    Article  PubMed  Google Scholar 

  51. Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: treatment with percutaneous microwave ablation – complications among cohort of 1136 patients. Radiology. 2009;251(3):933–40.

    Article  PubMed  Google Scholar 

  52. Brace CL. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Curr Probl Diagn Radiol. 2009;38(3):135–43.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China

    Zhigang Cheng MD & Ping Liang MD

Authors
  1. Zhigang Cheng MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ping Liang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ping Liang MD .

Editor information

Editors and Affiliations

  1. The Dept. of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China

    Ping Liang

  2. The Dept. of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China

    Xiao-ling Yu

  3. The Dept. of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China

    Jie Yu

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Cheng, Z., Liang, P. (2015). Percutaneous Microwave Ablation for Benign Focal Liver Lesions. In: Liang, P., Yu, Xl., Yu, J. (eds) Microwave Ablation Treatment of Solid Tumors. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-9315-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-9315-5_5

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-017-9314-8

  • Online ISBN: 978-94-017-9315-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation